Richard A. Gonzalez - Jul 31, 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
CHAIRMAN OF THE BOARD AND CEO, Director
Signature
T.O. Odutayo, attorney-in-fact for Richard A. Gonzalez
Stock symbol
ABBV
Transactions as of
Jul 31, 2023
Transactions value $
-$11,674,075
Form type
4
Date filed
8/2/2023, 05:07 PM
Previous filing
Mar 7, 2023
Next filing
Sep 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Sale -$2.76M -18.5K -2.87% $149.15 625K Jul 31, 2023 Direct F1
transaction ABBV Common Stock, $0.01 par value Sale -$8.91M -60K -9.6% $148.58 565K Aug 1, 2023 Direct F2
holding ABBV Common Stock, $0.01 par value 17.6K Jul 31, 2023 By Spouse F3
holding ABBV Common Stock, $0.01 par value 5.9K Jul 31, 2023 By Step-daughter F3
holding ABBV Common Stock, $0.01 par value 5.9K Jul 31, 2023 By Step-son F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.85 to $149.59 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.85 to $150.69 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reporting person disclaims beneficial ownership of these securities.